-
CytoDyn Appoints Seenu Srinivasan as Executive Director of CMC Regulatory Affairs
Market news
firstwordpharmaAugust 27, 2021
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company") announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.
-
Oasmia Appoints Head of Clinical Development & Head of Regulatory Affairs
Market news
firstwordpharmaAugust 27, 2021
Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021.
-
Electric Vehicle Sourcing and Procurement Market by 2024 | COVID-19 Impact & Recovery Analysis | SpendEdge
Market news
prnewswireAugust 27, 2021
The Electric Vehicle market is poised to grow by USD 275.22 Billion, progressing at a CAGR of almost 20.39% during the forecast period.
-
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
Market news
prnewswireAugust 27, 2021
RedHill Biopharma Ltd. today announced preliminary results of a new preclinical study showing strong inhibition by opaganib (ABC294640)[1] of Delta variant replication while maintaining cell viability at relevant concentrations.
-
PURO Air's Aurora UV Air Fan Proven 99.976% Effective Against Eradicating the Virus That Causes COVID-19 (Including Delta-Variant)
Market news
prnewswireAugust 27, 2021
PURO™ UV Disinfection Lighting announces today the results of an independent lab test proving its PURO Air Aurora UV Air Fan, offering continuous air disinfection, is effective in inactivating aerosolized SARS-CoV-2.
-
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
Market news
prnewswireAugust 27, 2021
INOVIO today announced that it has received regulatory authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária), the national health regulatory agency of Brazil, to initiate the global Phase 3 segment of its Phase 2/3 trial.
-
LOTTE HOTELS&RESORTS ready for global travelers with special services facing COVID-19
Market news
prnewswireAugust 27, 2021
Travel industry is moving fast as travel expectations rise, striving to meet customers' post-pandemic needs for stricter hygiene and safety, and provide services accordingly.
-
Colombia says welcome back to all cruises!
Market news
prnewswireAugust 27, 2021
The return of international cruise lines to Colombia is a reality. On Tuesday August 24th, the first cruise docked at the Port of Cartagena, after more than a year and a half without shipping companies arriving in Colombia.
-
Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
Market news
drugsAugust 26, 2021
Agios Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for mitapivat for the treatment of adults with pyruvate kinase (PK) deficiency.
-
FDA Approves Korsuva (difelikefalin) Injection for the Treatment of Moderate-to-Severe Pruritus in Hemodialysis Patients
Market news
drugsAugust 26, 2021
Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved Korsuva (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease.
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company") announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.
Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, today announces the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021.
The Electric Vehicle market is poised to grow by USD 275.22 Billion, progressing at a CAGR of almost 20.39% during the forecast period.
RedHill Biopharma Ltd. today announced preliminary results of a new preclinical study showing strong inhibition by opaganib (ABC294640)[1] of Delta variant replication while maintaining cell viability at relevant concentrations.
PURO™ UV Disinfection Lighting announces today the results of an independent lab test proving its PURO Air Aurora UV Air Fan, offering continuous air disinfection, is effective in inactivating aerosolized SARS-CoV-2.
INOVIO today announced that it has received regulatory authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária), the national health regulatory agency of Brazil, to initiate the global Phase 3 segment of its Phase 2/3 trial.
Travel industry is moving fast as travel expectations rise, striving to meet customers' post-pandemic needs for stricter hygiene and safety, and provide services accordingly.
The return of international cruise lines to Colombia is a reality. On Tuesday August 24th, the first cruise docked at the Port of Cartagena, after more than a year and a half without shipping companies arriving in Colombia.
Agios Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for mitapivat for the treatment of adults with pyruvate kinase (PK) deficiency.
Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved Korsuva (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease.
Pharma Sources Insight 08/2021
